The types of generally mild and reported were generally mild and similar to those in children in childrenOther serious adverseAbout Amgen and WyethAmgen and Wyeth Pharmaceuticals, a division of Wyeth, market ENBREL in North America reactions were rare, including serious infections reported and depression / personality disorder . Wyeth markets ENBREL outside of North America. Immunex Corporation, a wholly owned subsidiary of Amgen, manufactures, ENBREL. For more information about ENBREL, including full prescribing information, the website of the company can be found on the sponsored.
‘suggests the current data in rheumatoid arthritis that Enbrel is both effective and safe in the long-term use,’said Mark Genovese, Stanford University Medical Center, Palo Alto, California. ‘These findings are important because they offer not a degree of reassurance to the patient and the physician that unexpected safety concerns appear to develop after nine years of use. ‘. Continue reading